It is with sorrow that we have learned of the death in France on 29 October 2012 of Professor Serge Renaud, patriarch of the Renaud Society, at 84 years of age. In addition to being a colleague and close friend of many of us, he was celebrated as a pioneer in scientific research on the prevention of cardiovascular and other diseases. His innovative mind opened up new fields of inquiry that have greatly broadened research into the role of wine, alcohol, fatty acids, and other nutrients in preserving health and preventing disease.
Over many decades, Professor Renaud was the scientist who initiated much of the work relating the consumption of wine and other types of alcohol to cardiovascular disease and other of the diseases associated with ageing. He was the scientist most associated with the role of red wine in protecting the French from coronary artery disease (the "French Paradox"), and a leading figure in studying how other dietary factors relate to health. His innovative concepts have sometimes taken many years to be appreciated by other scientists. He made a major contribution with his research demonstrating how alpha-linolenic acid, monounsaturated fats, and other components of the "Cretan-type Mediterranean Diet," play key roles in promoting health.
Serge Renaud was born in Cartelègue, Haute Gironde, France, and after starting his medical training in France moved to Montreal, Canada, and later to Boston, Massachusetts, USA. He returned to France in 1973 and became director of the INSERM unit in Lyon, France, where much of his research was carried out.
In an excellent tribute to Renaud in the Lancet in 2000, Bruno Simini points out his major contributions investigating the association between wine, diet, and thrombosis. Simini quotes Serge as saying: “If I hadn't lived with my grandparents and great-grandparents on a vineyard near Bordeaux, perhaps this idea wouldn't have occurred to me. When you see people reach the age of 80 or 90 years, who have been drinking small amounts of wine every day, you don't believe wine in low doses is harmful.”1
In 1991, Serge Renaud appeared on the popular US television program, “60 Minutes,” in a segment entitled the “French Paradox.” When asked by Morley Safer, the host, what was the real reason that the French have rates of coronary artery disease so much lower than those in other developed nations, Renaud replied: “I think it is the alcohol.” And when Morley Safer closed the segment holding a glass of red wine and saying, “The protection of the French from heart disease may rest in this inviting glass,” the response in the US was remarkable – nothing such as this had ever been stated in the country that earlier in the century had made any alcohol consumption illegal through nation-wide prohibition. Following the television program, sales of red wine rose immediately by 40 per cent!
In addition to his studies on wine and alcohol, Professor Renaud, noting the very low rates of heart disease among participants from Crete in the “Seven Countries Study,” initiated the Lyon Diet Heart Study in 1985 to determine the effects of a diet based on that of Crete on the course of disease among patients who already had coronary disease. There were very dramatic reductions in subsequent coronary problems and in total mortality among subjects given the “Cretan-type diet,” which contained increased levels of an omega-3 fatty acid (alpha-linolenic acid) to replace some of the fats from meat and dairy products.
As quoted in the Lancet tribute by Simini, Professor Renaud said the results of these studies on heart disease and cardiac arrhythmias made him “wonder about the origins of civilisations. It is intriguing that ancient Asian and Mediterranean civilisations used natural oils in cooking—colza and olive—with similar fatty acid compositions.” [Colza oil is closely related to the widely used rapeseed oil and canola oil.] And because of his belief in ancient wisdom when it comes to diet and health, Renaud ends his book Le régime santé2 with a warning: “Don't look for a pill that replaces [the Cretan diet]. There is no such thing.”
People around the world have profited, and will continue to profit, from the lifelong scientific work of Serge Renaud. For those of us who knew and worked with Serge, we all cherish our memories of Serge the person, and of Serge the consummate scientist. The Renaud Society will continue to honor the life contributions of its patriarch, Professor Renaud, with academic and fraternal pursuits that would be very pleasing to him and respectful to his memory.
1. Simini B. Serge Renaud: From French Paradox to Cretan miracle. doi:10.1016/S0140-6736(05)71990-5.
2. Renaud S. Le régime santé. Odile Jacob, Paris, 1998.
A Tribute to Federico Leighton Puga, MD — 8 May 2012
Frederico Leighton Puga, MD, Professor and Director of the Center for Molecular Nutrition and Chronic Diseases of the Catholic University of Chile in Santiago, died on 27 April 2012 at the age of 74 years. Dr. Leighton was a valued member of the International Scientific Forum on Alcohol Research, and was noted for his seminal work in nutrition, antioxidants, the health aspects of moderate wine consumption, and public health approaches for the prevention of chronic diseases.
Many Forum members knew and had worked with Dr. Leighton through many decades. All feel a deep loss, of a great scientist, a loyal and good friend, and someone very concerned with the health of people everywhere. As stated by one Forum member, “Federico was a great scientist motivated by curiosity and the desire to be useful for his country. His culture and education and intellectual rigor were well integrated into his humanity and the sweetness of his character.” Another commented that Federico was a passionate investigator and a honest advocate for the science of diet, wine, alcohol and health. Said another: “Federico had in abundance that indefinable quality known as ‘class.’” The world has lost an honest and honorable scientist.
Among the notable achievements of Dr. Leighton’ s scientific career were numerous experiments of the effect of moderate wine and alcohol consumption on risk factors for cardiovascular disease. In a key publication in 2005, Dr. Leighton and his colleagues demonstrated a central role of eNOS in the protective effect of wine against metabolic syndrome. His research demonstrated beneficial effects of wine/alcohol intake on lipid factors (HDL cholesterol, triglycerides, omega-3/omega-6 fatty acids ratio); hemostasis (fibrinogen, PAI-I, thrombosis, factor VIIc); endothelial function; blood pressure; inflammation (PCR hs, cytokines and others); oxidative stress (damage to DNA, lipids and proteins, antioxidant levels); insulin sensitivity; and anthropometric parameters (BMI, abdominal circumference).
Further, in an article in 2007, Dr. Leighton stated that the studies carried out by him and his colleagues showed that “Moderate wine consumption improves antioxidant defenses (plasma antioxidant capacity, ascorbate, beta-carotene, and total polyphenols) and counteracts oxidative damage (8-OHdG, nitrotyrosine). Endothelial function improves while blood pressure has shown inconsistent results.”
Dr. Leighton summarized these studies: “From our observations, we consider that wine in moderation, as part of the diet, should decrease the risk of cardiovascular disease. The results should take into consideration that there are many cardiovascular risk factors and that their response to moderate wine consumption is not uniform; yet, significant positive changes are observed for a large number of them.”
Dr. Leighton was an international leader in nutritional studies of wine and diet, hosting one of the first Wine and Health symposia, Vinsalud, in Santiago in 2002. With over 100 participants from around the world, the success of this meeting launched a series of such meetings that continues today. He was also successively a former Scientific Secretary and an efficient Vice-President of the Wine, Nutrition and Health Sub-commission of the Organisation Internationale de la Vigne et du Vin (OIV). He brought forth several contributions in OIV resolutions, notably one recommending that OIV member states support further research in the field of wine and health; such research should serve as the basis for public health and education policies.
In addition to his experiments among subjects evaluating the effects on cardiovascular risk factors of a Mediterranean diet and wine consumption , Dr. Leighton led important public health measures in Chile. One project, Science, Wine and Health, tested the effects on the population of the Mediterranean Diet and of moderate wine consumption. An evaluation after completion of the public campaign revealed that while the total amount of alcohol consumed by the Chilean people changed very little, they were more likely to consume smaller amounts of alcohol on a more frequenet basis, and with meals, than before the program; binge drinking decreased. Thus, his work was instrumental in convincing the public to adopt healthier patterns of alcohol consumption and to avoid its adverse effects.
Dr. Ines Urquiaga, who was his student and colleague, described how his work benefitted his home country: “Since 2000 Dr. Leighton was dedicated to promoting Mediterranean food in the country, researching the effects and benefits, and creating programs that introduced and encouraged this healthy diet — to both white and blue collar laborers. In this way, he sought to improve the health of all Chileans.” Dr. Urquiaga added: “I am grateful to have learned from Dr. Leighton’s enthusiasm for doing good things for others. He was a lover of science and enthusiastic about life.”
* * *
Alberto Bertelli, MD, PhD, Institute of Human Anatomy, University of Milan, Italy.
Dee Blackhurst, PhD, Lipid Laboratory, University of Cape Town Health Sciences Faculty, Cape Town, South Africa.
Giorio Calabrese, MD, Docente di Dietetica e Nutrizione, Umana Università Cattolica del S. Cuore, Piacenza, Italy.
Maria Isabel Covas, DPharm, PhD, Cardiovascular Risk and Nutrition Research Group, Institut Municipal d´Investigació Mèdica, Barcelona, Spain.
Alan Crozier, PhD, Plant Biochemistry and Human Nutrition, University of Glasgow, Scotland, UK.
Giovanni de Gaetano, MD, PhD, Research Laboratories, Catholic University, Campobasso, Italy.
Luc Djoussé, MD, DSc, Dept. of Medicine, Division of Aging, Brigham & Women’s Hospital and Harvard Medical School, Boston, MA, USA.
Alun Evans, MD, Centre for Public Health, The Queen’s University of Belfast, Belfast, UK.
Harvey Finkel, MD, Hematology/Oncology, Boston University Medical Center, Boston, MA, USA.
Tedd Goldfinger, DO, FACC, Desert Cardiology of Tucson Heart Center, Dept. of Cardiology, University of Arizona School of Medicine, Tucson, Arizona, USA.
Lynn Gretkowski, MD, Obstetrics/Gynecology, Mountainview, CA, Stanford University, Stanford, CA, USA.
Dwight Heath, PhD, Dept. of Anthropology, Brown University, Providence, RI, USA.
Oliver James, MD, Head of Medicine, University of Newcastle, UK.
Ulrich Keil, MD, PhD, Institute of Epidemiology and Social Medicine, University of Münster, Münster, Germany.
Arthur Klatsky, MD, Dept. of Cardiology, Kaiser Permanente Medical Center, Oakland, CA, USA.
Maritha J. Kotze, PhD,Human Genetics, Dept of Pathology, University of Stellenbosch, Tygerberg, South Africa.
Ross McCormick PhD, MSC, MBChB, Associate Dean, Faculty of Medical and Health Sciences, The University of Auckland, Auckland, New Zealand.
Francesco Orlandi, MD, Dept. of Gastroenterology, Università degli Studi di Ancona, Italy.
Lynda Powell, MEd, PhD, Chair, Dept of Preventive Medicine, Rush University Medical School, Chicago, IL, USA.
Ian Puddey, MD, Dean, Faculty of Medicine, Dentistry & Health Sciences, University of Western Australia, Nedlands, Australia.
Erik Skovenborg, MD, Scandinavian Medical Alcohol Board, Practitioner, Aarhus, Denmark.
Jan Snel, PhD, Social and Behavioral Sciences, University of Amsterdam, Amsterdam, Holland.
Jeremy P E Spencer, Reader in Biochemistry, The University of Reading, UK.
Creina Stockley, MSc, MBA, Clinical Pharmacology, Health and Regulatory Information Manager, Australian Wine Research Institute, Glen Osmond, South Australia, Australia.
Arne Svilaas, MD, PhD, general practice and lipidology, lo University Hospital, Oslo, Norway.
Pierre-Louis Teissedre, PhD, Faculty of Oenology – ISVV, University Victor Segalen Bordeaux 2, Bordeaux, France.
Gordon Troup, MSc, DSc, School of Physics, Monash University, Victoria, Australia.
Fulvio Ursini, MD, Dept. of Biological Chemistry, University of Padova, Padova, Italy.
David Vauzour, PhD, Senior Research Associate, Department of Nutrition, Norwich Medical School, University of East Anglia, Norwich, UK.
David Van Velden, MD, Dept. of Pathology, Stellenbosch University, Stellenbosch, South Africa.
Andrew L. Waterhouse, PhD, Marvin Sands Professor, Department of Viticulture and Enology, University of California, Davis; Davis, CA, USA.
Yuqing Zhang, MD, DSc, Epidemiology, Boston University School of Medicine, Boston, MA, USA.
Co-Directors of International Scientific Forum on Alcohol Research:
R. Curtis Ellison, MD, Section of Preventive Medicine & Epidemiology, Boston University School of Medicine, Boston, MA, USA.
Helena Conibear, Executive Director, AIM-Alcohol in Moderation, Dorset, UK.
We're now on FACEBOOK! www.facebook.com and search for the Renaud Society Sign Up ~ and begin blogging! Wine Reviews Post Images and Videos Communicate with members Wine - Health Information Review or Post Events
The Renaud Society is saddened to report the untimely passing of Tom Shelton, Past president and CEO, Joesph Phelps Vineyards, Napa, California, and Honorary Co-Chairman of the 4th International Wine & Heart Health Summit, 2007.. Tom was a friend to the Renaud Society, an avid supporter of wine and health initiatives, and a quality individual who made a significant impact in American wine culture. His absence will be missed, and his memory, most cherished.
Tom Shelton, Honorary Co-Chair, 4th International Wine & Heart Health Summit, seen here with Professor Serge Renaud, 2007
Tom Shelton: A Classy Guy
Posted: 12:57 PM ET, July 29, 2008, by James Laube
You think you know things about people, but of course you can only know so much. I knew the severity of Tom Shelton’s health in the past week, since so many of his friends kept me in the loop out of their love and concern for him and his family. But I didn’t know much about his passion for golf (and working as a caddy to earn spending cash in college) or his love of biking. Those tidbits only came out while preparing his obituary, which is always an awkward assignment, no matter who you’re writing about. When Tom died this past weekend it hit many people pretty hard. In my case, we were close in age and had both worked in wine for many years. Tom and I were on the opposite sides of the business. He ran a major winery and I wrote about its wines and in this role the writer usually gets the final word. I came to know him as part of a one-two punch for Joseph Phelps Vineyards. He was the president and CEO and Craig Williams was the winemaker. As part of Tom’s duties he became a spokesman for the Napa Valley Vintners and whatever issues it faced. One challenge he helped spearhead was the NVV's efforts to protect the Napa Valley appellation and strengthen labeling laws so that when you bought a bottle of Napa wine it came from Napa. He also worked on committees aimed at making it easier for consumers to buy wine direct from wineries. Both of those assignments were perhaps less compelling for Tom. I’m sure he would have rather focused more exclusively on Phelps’ winemaking and to be sure he did, both in building the winery’s quality and reputation and starting the Freestone project. But he took on the other more bureaucratic assignments like a true soldier and commander because they went with the territory. I often marveled at how well, and how patient he was in explaining to writers the intricacies of laws pertaining to both. When it came to wine matters I didn’t have much direct interaction with Tom. Most of the time I talked with Craig. Still I remember one morning a few years ago when I had two calls on my answering machine—both Tom and Craig wanted me to call them. I wasn’t entirely sure what they wanted, but it was unusual to hear from both of them at about the same hour. Winemakers seldom call except to question a review, and of course, that was the case. I first spoke with Tom, who said some customers had called seeking to return their 2001 Backus Cabernet, having read my review. He hadn’t seen the note, but it was in print and he asked what it said. I told him, half expecting him to raise his voice about my calling it “mulchy” and object to the 79-point rating. But he didn’t. He calmly said words to the effect of, "Well, I was afraid that wine wouldn’t go over very well with you." And that was it. Thanks for returning his call. Next came Craig’s call and he had the same reaction. The wine had been bottled unfiltered and developed a green olive earthiness that was quite different from a typical Backus and much less compelling than the 2001 Insignia, which gushed with fruit purity. I asked Craig if I had missed something, or if the bottles we’d received had been off, and he, like Tom, didn’t dodge the matter. No, the wine had its issues and both he and Tom thought the review was fair even if they didn’t like it and might have rated the wine slightly higher, as in 82 points. The next vintage, both Tom and Craig were happier campers. The 2002 Insignia was chosen as Wine Spectator’s Wine of the Year, a big feather in both their hats. When I ran into Tom shortly after that announcement he was the same Tom, cool, calm and collected. But I remember the happy grin and his comment about how he and Craig had "gotten it right this time" and by the way, so had I. I'll remember him as a classy guy.
Society Commissions Noted British Artist Ron Dutton to Design the Renaud Society Medal
"Following studies in painting, sculpture, and fine arts at Kings College, University of Durham (1960), I taught at the Sunderland and Wolverhamptom Colleges of Art (UK). For a period of twenty five years, from 1961 through 1985, I had the opportunity shared the enjoyment and enthusiasm of both fellow staff and students and a time for making works primarily in sculpture. In 1974 the medal became a focus of expression that has offered stimulating and challanging opportunities I am grateful to have found. Since 1985, I have been a full time practising medal artist."
For more information on Mr. Ron Dutton, please visit www.rondutton.co.uk
The Renaud Society to honor its members at the 4th International Wine & Heart Health Summit in Napa.
The Renaud Medal is to be bestowed on the membership at a gala banquet and charity auction supporting the Desert Heart Foundation Wine & Heart Health Initiative, An Affair of the Heart, held at the Culinary Institute of America, St. Helena, California.
All members are strongly encouraged to attend this event!
Goldfinger Releases Book on Wine & Health, Diet & Weight Loss
Dr. Tedd Goldfinger, founding physician of the Renaud Society releases his first book August 25th, 2006; The Wine Lovers Healthy Weight Loss Plan.
A project created by Goldfinger and noted Oregon Chef, Lynn Nicholson, this book professes the health benefits of a sensible diet and moderate daily wine consumption for better health and weight control. It is to be published by McGraw Hill, New York, and is available right now
Serge Renaud, PhD. has contributed the forward to this book
The Renaud Society releases its first wine produced by careful blending, and bottled exclusively for the Renaud Society
The Inauguaral wine of the Renaud Society was produced by the Bernard Manien family of Bordeaux (Beychac-Calliou) at Domaines des Grandes Cotes. A small right bank producer in the region of Bordeaux Superior, this wine is dominated by their lucious Merlot and rounded-out with Cabernet Sauvignon and Cabernet Franc all grown and family picked at their home vineyard.
Their modest stone house, where three generations live and work together, is characteristic for the area, and surrounded by aromatic lavendar and herbs. What an opportunity to find such a welcoming family. We are proud to have the Renaud Society banner proudly displayed at the Domaines des Grandes Cotes - Familie Manien
In the area? For information about visits to the winery send inquiry to:
Renaud Society launched with great enthusiasm at the 3rd International Wine & Heart Health Summit, Napa, California - 2005
By Elisabeth Holmgren
More than 200 physicians from around the world attended the 3rd International Wine & Heart Health Summit held at the Silverado Country Club & Resort in Napa, California. The Summit was cosponsored by Desert Heart Foundation and the Wine Spectator. The four-day symposium brought together an impressive faculty of physicians, scientists and epidemiologists to discuss the health effects of the daily consumption of wine, beer or spirits on improved cardiovascular health.
Tedd M. Goldfinger, DO, FACC, Chairman of the International Wine & Heart Health Summit emphasized in his opening remarks that the delegates attending from around the globe act as important ambassadors for the promotion
of a healthy lifestyle. He reiterated that in light of the emerging science, “It is prudent for physicians to discuss the harmful effects of alcohol with their patients, while at the same time, not discourage a potentially healthy practice of wine in moderation with meals.” In fact, the presentations from many world renowned experts revealed that research often reports more pronounced cardiovascular benefits among wine drinkers. At the same time, however, many investigators increasingly explained that this may be due to wine drinkers’ overall healthier lifestyles. This article presents some of the key statements made by some of the presenters who concentrated on the subject of wine, alcohol and cardiovascular health.
R. Curtis Ellison, MD from Boston University School of Medicine outlined how wine has been considered the ‘healthiest of beverages’ since ancient times until the 20th century. Through prohibition in the USA, essentially no research was done on alcohol and health for many decades. In fact, in 1974, the Framingham Heart Study was blocked by the National Institute of Health from publishing findings showing striking reductions in coronary heart disease (CHD) deaths from moderate drinking. This was triggered by concerns that such information might foster abuse. As the research on moderate wine, beer and spirits consumption and potential coronary heart disease benefits emerged, the scientific, media and policy communities acknowledged the reported lifestyle benefits to the public. Ellison explained, “The mechanisms of such protection have been extensively studied: they include beneficial effects of alcohol and/ or wine polyphenolic substances on blood lipids, lipid oxidation, coagulation, fibrinolysis, arterial endothelial function, ventricular function, inflammation, and glucose metabolism.” He outlined the recent research developments demonstrating potential benefits for subjects who already have developed CHD by showing fewer recurrent infarcts and repeat percutaneous cardiac interventions, as well as overall lower death rates for moderate drinkers. In addition, Ellison presented an overview on studies that found protection from alcohol on the risk of cognitive decline, on all components of the metabolic syndrome and the possible protection against weight gain. In the closing statement, he emphasized that “For the first time in decades, wine and other alcoholic beverages, in moderation, are now being considered an important part of a ‘healthy lifestyle.” Lending even more scientific support to this trend, Ellison outlined the recent research that has also shown the importance of the pattern of drinking, with the most favorable effects being seen from the daily consumption with meals.
Serge Renaud, PhD from SegalenUniversity in Bordeauxpresented an overview of the findings from the Lyon Heart Study. The important findings demonstrate how nutrition and lifestyle habits can lead to better health and increased life expectancy. In fact, according to Renaud the evidence is stronger then ever that a healthy diet that includes wine and specifically red wine is the main protector against coronary heart disease. Specifically, findings from the Lyon Diet Heart Study illustrate the potential: importance of a dietary pattern that emphasizes fruits, vegetables, breads and cereals, and fish, as well as alpha-linolenic acid as found in vegetable oils such as flaxseed and canola oil. Traditionally, the diet also includes moderate amounts of alcohol. Renaud reiterated that “it would be short sighted to not recognize the enormous public health benefit that this diet could confer
with adoption by the population-at-large if the findings are confirmed.” He and other experts have long encouraged US public health organizations such as the American Heart Association to take these important findings into account when providing messages to the public.
Arthur Klatsky, MD, Senior Consultant in Cardiology from the Kaiser Permanente Medical Program in Oaklandpresented findings on beverage choice and coronary heart disease (CHD) risk. Klatsky explained that in the past decade most relevant reports of beverage choice differences have been cohort or case control studies with data about individuals. He stated, “While not unanimous, these data support the probability that CHD is lower in wine drinkers than in beer and liquor drinkers”. He further added that “several reports from countries with no preponderant beverage choice such as Denmark and the US show that other lifestyle habits such as drinking patterns, socio economic status, diet, and smoking habits are more favorable for wine drinkers.” Klatsky explained that this is a fact often used to challenge a causal hypothesis with respect to observed beverage choice differences in CHD risk and added that it can not be ignored that “numerous reports of non-alcoholic compounds in wine, especially red, with hypothetically beneficial actions against athereo-thrombotic disease offer biological plausibility to additional benefit of wine.” Most significantly, Klatsky presented data from the world renowned Kaiser Permanente study, outlining that data collected in 1978-1985 among 129,000 persons supplied information about total alcohol intake and frequency of drinking beverage types. Recent studies include all beverage choice data as frequency variable in analyses with results indicating the independent relationships of the beverage types. Data collected in 1997 showed lower risk of CHD hospitalization for both beer and wine frequency than liquor, and a 2003 reportrobustly showed lower risk related to frequency of wine drinking for total mortality and CHD death. New data about heart failure risk also reveal wine frequency to be associated with reduced risk. Klatsky further added that in none of these studies was there a difference for drinkers of red and white wine. In his closing statements, Klatsky explained, “It is now clear that frequent wine drinkers have lower risks than beer or liquor drinkers. However, it remains unresolved whether this is due to nonalcoholic wine ingredients, drinking pattern or traits associated with wine drinking.” These findings from the Kaiser Permanente study have also been echoed through ongoing results from the Copenhagen Centre for Prospective Population Studies such as the Copenhagen City Heart Study.
Morton Gronbaek, MD, PhD from the Danish National Institute of Public Health, spoke on the subject of alcohol and cancer and specifically breast cancer, colon and rectal cancer which are of increasing concern in populations around the globe. He presented data on alcohol intake, drinking patterns and risk of postmenopausal breast cancer “showing a monotonic increase in the risk of breast cancer among postmenopausal women with increasing average daily intake of alcohol, and this relationship with alcohol intake did not depend on drinking frequency.” Furthermore, Gronbaek addressed the relations between amount and type of alcohol and colon and rectal cancer. He explained that their study provides evidence of a causal relationship between alcohol and rectal cancer. However, he outlined the exact data demonstrating that “The carcinogenic effect of alcohol on rectal cancer appears to be reduced when wine is included in alcohol intake.” According to Gronbaek and his colleagues, “This suggests an anti-carcinogenic effect of wine, consistent with the findings of experimental studies.”
Francois Booyse, MD from the University of Alabama at Birminghamprovided an overview of his ongoing research addressing the molecular basis for the health benefits of wine. He and his team of experts have found that wine components— alcohol and individual principal polyphenols—can exert a diverse array of biological effects on systemic circulatory components and myocardial function. Specifically, his team has conducted ongoing studies with cell culture/ animal models combined with state-of-the art methods such as micro array gene analysis that are used to delineate the molecular basis and mechanisms by which individual wine components activate endothelial cells tag the cellular, molecular and gene levels to increase and sustain their clot dissolving potential. Booyse explained, “The combined ability of wine components to simultaneously increase systemic fibrinolysis, in conjunction with the described suppression of the coagulation system and platelet function, will be expected to provide substantial cardio protection by reducing the overall risk for early initiation of thrombosis and atherogenesis, as well as the later CAD related athero-thrombotic consequences of myocardial infarction, stroke and CAD related mortality.” This cutting-edge research will be of major significance over the years to come as it is a fundamental cornerstone for lending more evidence to the potential health advantages of moderate drinking. Last year, AIM developed a major website section on this ongoing research and you can learn more about it by visiting
There were several other presentations by media, industry and other experts which provided other interesting aspects on wines from around the world. The last discussion featuring the ‘Physicians in Wine Panel- A Blend of Medical Practice
& Wine Culture’ underscored the importance of the ongoing research findings on moderate wine, alcohol consumption and health. Overall, it was emphasized that messages on the moderate and responsible enjoyment of wine and alcohol should be maintained as an important educational component. Towards this end, Dr. Goldfinger outlined how the Desert Heart Foundation launched The Renaud Society. He explained how the Society has been named for the ‘iconic pioneer in the field of wine and health’ and hopes to expand its network of physicians interested in the pleasures of wine and a healthy way of life’. The Renaud Society will offer a regular newsletter, annual special events, as well as trips and tours to wine regions around the world. To learn more about the different activities of the Society, please write to email@example.com.